SEC 13F Intelligence

Global Imc LLC / BBIO

Global Imc LLC’s Bridgebio Pharma Inc Position

Does Global Imc LLC own Bridgebio Pharma Inc (BBIO)? Not currently — the last reported position was 109.4K shares worth $5M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q2 2025
Shares
109.4K
% of Portfolio
+1.22%
Quarters Held
5
position exited

Position History BBIO

Reported value by quarter
Q1 ’23: $4MQ1 ’23Q2 ’23: $4MQ2 ’23Q3 ’23: $4MQ3 ’23Q4 ’23: $5MQ4 ’23Q2 ’25: $5MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025109.4K$5M+1.22%
Q4 2023118.1K$5M+1.15%
Q3 2023141.5K$4M+1.01%
Q2 2023223.2K$4M+1.13%
Q1 2023223.2K$4M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Global Imc LLC’s full portfolio or all institutional holders of BBIO.